Black-box warnings on Rx products up sharply in '07

Document Sample
Black-box warnings on Rx products up sharply in '07 Powered By Docstoc
					Bl
				
DOCUMENT INFO
Description: Black-box warnings on pharmaceutical products continued to surge upward in 2007. The FDA's MedWatch reporting system showed that black-box warnings rose 26% to 73% in 2007 from 58% in 2006, according to IMS Health's US Pharmaceutical Market Performance Review, issued in March. As pharmaceutical product safety issues and warnings increase, they have a noticeable impact on the total market, the IMS Health report stated. Scrunity on the value of medicine and what those medicines will bring to the market are going to be key trends going to 2008.
BUY THIS DOCUMENT NOW PRICE: $6.95 100% MONEY BACK GUARANTEED
PARTNER ProQuest LLC
ProQuest creates specialized information resources and technologies that propel successful research, discovery, and lifelong learning.